Amyloid diagnostics in rheumatic diseases;Amyloiddiagnostik bei rheumatischen erkrankungen

Pathologe

Volumn 27, Issue 6, 2006, Pages 422-430

  Rocken C ^a   Ernst, J ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Klinik fur Internistische Rheumatologie   (Germany)

Author keywords

Amyloid; Amyloidosis; Classification; Protein deposits; Rheumatic diseases

Indexed keywords

AMYLOID; ENDOGENOUS COMPOUND; IMMUNOGLOBULIN D;

AMYLOIDOSIS; CHRONIC DISEASE; COLOR; HUMAN; PROGNOSIS; RECURRENT FEVER; REVIEW; RHEUMATIC DISEASE; STAINING; TISSUE SLICE; TREATMENT PLANNING;

AMYLOIDOSIS; COLORING AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERGAMMAGLOBULINEMIA; RHEUMATIC DISEASES;

EID: 33845431256     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-006-0861-y     Document Type: Review

References (50)

1. Bohne S, Sletten K, Menard R, Bühling F et al. (2004) Cleavage of AL amyloid proteins and AL amyloid deposits by cathepsins B, K, and L. J Pathol 203: 528-537
2. Brandt K, Cathcart ES, Cohen AS (1968) A clinical analysis of the course and prognosis of forty-two patients with amyloidosis. Am J Med 44:955-969
3. Browning MJ, Banks RA, Tribe CR et al. (1985) Ten years' experience of an amyloid clinic - a clinicopathological survey. Q J Med 54: 213-227
4. Charra B, Calemard E, Uzan M et al. (1985) Carpal tunnel syndrome, shoulder pain and amyloid deposits in long-term haemodialysis patients. Proc Eur Dial Transplant Assoc Eur Ren Assoc 21: 291-295
5. Ensari C, Ensari A, Tumer N et al. (2005) Clinicopathological and epidemiological analysis of amyloidosis in Turkish patients. Nephrol Dial Transplant 20: 1721-1725
6. Ernst J, Wienands K, Mayer-Schlagintweit S et al. (1997) Can specific laboratory constellations improve the indication for rectal biopsy and thus contribute to the early diagnosis of AA amyloidosis in inflammatory rheumatic diseases? Clin Neuropathol 16: 49
7. Gertz MA, Kyle RA (1991) Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 70: 246-256
8. Gertz MA, Lacy MQ, Dispenzieri A (2002) Immunoglobulin light chain amyloidosis and the kidney. Kidney Int 61: 1-9
9. Gillmore JD, Lovat LB, Persey MR et al. (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358: 24-29
10. Grateau G (2003) Musculoskeletal disorders in secondary amyloidosis and hereditary fevers. Best Pract Res Clin Rheumatol 17: 929-944
11. Greenstein AJ, Sachar DB, Panday AK et al. (1992) Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine Baltimore 71: 261-270
12. Gregorini G, Izzi C, Obici L et al. (2005) Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis. J Am Soc Nephrol 16: 3680-3686
13. Hazenberg BP, Van Rijswijk MH (1994) Clinical and therapeutic aspects of AA amyloidosis. Baillieres Clin Rheumatol 8: 661-690
14. Hazenberg BPC, Vanrijswijk MH (2000) Where has secondary amyloid gone? Ann Rheumatic Dis 59: 577-579
15. Helin HJ, Korpela MM, Mustonen JT et al. (1995) Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum 38: 242-247
16. Hook V, Toneff T, Bogyo M et al. (2005) Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's disease. Biol Chem 386: 931-940
17. Ishii W, Matsuda M, Nakamura N et al. (2003) Phenol Congo red staining enhances the diagnostic value of abdominal fat aspiration biopsy in reactive AA amyloidosis secondary to rheumatoid arthritis. Intern Med 42: 400-405
18. Janssen S, Rijswijk MHv, Meijer S et al. (1986) Clinical evaluation of AA and AL amyloid disease. In: Marrink J, Van Rijswijk MH (eds) Amyloidosis. M.Nijhoff Publ, Dordrecht-Boston-Lancester, pp 61-72
19. Kaipiainen-Seppänen O, Myllykangas-Luosujärvi R, Lampainen E, Ikaheimo R (2000) Intensive treatment of rheumatoid arthritis reduces need for dialysis due to secondary amyloidosis. Scand J Rheumatol 29: 232-235
20. Kaplan B, Hrncic R, Murphy CL et al. (1999) Microextraction and purification techniques applicable to chemical characterization of amyloid proteins in minute amounts of tissue. Methods Enzymol 309: 67-81
21. Kazatchkine MD, Husby G, Araki S et al. (1993) Nomenclature of amyloid and amyloidosis - WHOI-UIS nomenclature sub-committee. Bull WHO 71: 105-108
22. Kebbel A, Röcken C (2006) Immunohistochemical classification of amyloid in surgical pathology revisited. Am J Surg Pathol 30: 673-683
23. Kobayashi H, Tada S, Fuchigami T et al. (1996) Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol 35: 44-49
24. Kuroda T, Tanabe N, Sakatsume M et al. (2002) Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amyloidosis in rheumatoid arthritis. Clin Rheumatol 21: 123-128
25. Laiho K, Tiitinen S, Kaarela K et al. (1999) Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland. Clin Rheumatol 18: 122-123
26. Linke RP (2000) Highly sensitive diagnosis of amyloid and various amyloid syndromes using Congo red fluorescence. Virchows Arch 436: 439-448
27. Magnus JH, Stenstad T (1997) Proteoglycans and the extracellular matrix in amyloidosis. Amyloid 4: 121-134
28. Maury CP, Liljestrom M, Laiho K et al. (2003) Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. Arthritis Rheum 48: 3068-3076
29. Maury CP, Tiitinen S, Laiho K et al. (2002) Raised circulating interleukin-18 levels in reactive AA-amyloidosis. Amyloid 9: 141-144
30. Merlini G, Bellotti V (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349: 583-596
31. Myllykangas-Luosujärvi R, Aho K, Kautiainen H et al. (1999) Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology 38: 499-503
32. Nakano M, Ueno M, Nishi S et al. (1998) Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis. Clin Nephrol 50: 154-160
33. Obici L, Manno C, Muda AO et al. (2004) First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheum 50: 2966-2969
34. Olsen KE, Sletten K, Westermark P (1999) The use of subcutaneous fat tissue for amyloid typing by enzyme- linked immunosorbent assay. Am J Clin Pathol 111: 355-362
35. Pras M, Itzchaki M, Prelli F et al. (1985) Amyloid arthropathy: characterization of the amyloid protein. Clin Exp Rheumatol 3: 327-331
36. Puchtler H, Sweat F, Levine M (1962) On the binding of Congo red by amyloid. J Histochem Cytochem 10: 355-364
37. Röcken C, Ernst J, Hund E et al. (2006) Interdisziplinäre Leitlinien zur Diagnostik und Therapie der extrazerebralen Amyloidosen. DMW 27: S45-S66
38. Röcken C, Kronsbein H, Sletten K et al. (2002) Amyloidosis of the breast. Virchows Arch 440: 527-535
39. Röcken C, Menard R, Bühling F et al. (2005) Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation. Ann Rheum Dis 64: 808-815
40. Röcken C, Schwotzer E, Linke RP et al. (1996) The classification of amyloid deposits in clinicopathological practice. Histopathology 29: 325-335
41. Röcken C, Shakespeare A (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440: 111-122
42. Röcken C, Sletten K (2003) Amyloid in surgical pathology. Virchows Arch 443: 3-16
43. Röcken C, Tautenhahn J, Bühling F et al. (2006) Prevalence and pathology of amyloid in atherosclerotic arteries. Arterioscler Thromb Vasc Biol 26: 676-677
44. Tanaka F, Migita K, Honda S et al. (2003) Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp Rheumatol 21: 343-346
45. Tishler M, Pras M, Yaron M (1988) Abdominal fat tissue aspirate in amyloidosis of familial Mediterranean fever. Clin Exp Rheumatol 6: 395-397
46. Tuglular S, Yalcinkaya F, Paydas S et al. (2002) A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant 17: 2003-2005
47. Varga J, Idelson BA, Felson D et al. (1987) Lack of amyloid in abdominal fat aspirates from patients undergoing long-term hemodialysis. Arch Intern Med 147: 1455-1457
48. Wester AL, Vatn MH, Fausa O (2001) Secondary amyloidosis in inflammatory bowel disease: a study of 18 patients admitted to Rikshospitalet University Hospital, Oslo, from 1962 to 1998. Inflamm Bowel Dis 7: 295-300
49. Westermark P, Stenkvist B (1973) A new method for the diagnosis of systemic amyloidosis. Arch Int Med 132: 522-523
50. Yamada M, Hatakeyama S, Tsukagoshi H (1985) Gastrointestinal amyloid deposition in AL (primary or myeloma-associated) and AA (secondary) amyloidosis: diagnostic value of gastric biopsy. Hum Pathol 16: 1206-1211